Source:http://linkedlifedata.com/resource/pubmed/id/20957171
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
2010-10-19
|
pubmed:abstractText |
We aimed to evaluate whether the enhancement of the liver accumulation and anti-inflammatory activity of dexamethasone acetate (DXMA) could be achieved by incorporating it into nanostructured lipid carrier (NLCs). DXMA-NLCs were prepared using a film dispersion-ultrasonication method and characterized in terms of particle size, PDI, zeta potential, differential scanning calorimetry, drug loading capacity, encapsulation efficiency, and in vitro release. The biodistribution and pharmacokinetics of DXMA-NLCs in mice were significantly different from those of the DXMA solution (DXMA-sol). The peak concentration of DXMA-NLCs was obtained half an hour after intravenous administration. More than 55.62% of the total administrated dose was present in the liver. An increase of 2.57 fold in the area under the curve was achieved when compared with that of DXMA-sol. DXMA-NLCs exhibited a significant anti-inflammatory and hepatoprotective effect on carrageenan-induced rats and carbon tetrachloride-induced mice compared with DXMA-sol. However, the effect was not in proportion to the dosage. The intermediate and low dosages presented better effects than DXMA-sol. All results indicate that NLCs, as a novel carrier for DXMA, has potential for the treatment of liver diseases, increasing the cure efficiency and decreasing the side effects on other tissues.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Anti-Inflammatory Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Carbon Tetrachloride,
http://linkedlifedata.com/resource/pubmed/chemical/Carrageenan,
http://linkedlifedata.com/resource/pubmed/chemical/Dexamethasone,
http://linkedlifedata.com/resource/pubmed/chemical/Drug Carriers,
http://linkedlifedata.com/resource/pubmed/chemical/Liposomes,
http://linkedlifedata.com/resource/pubmed/chemical/dexamethasone acetate
|
pubmed:status |
MEDLINE
|
pubmed:issn |
1178-2013
|
pubmed:author |
pubmed-author:HuangYuanY,
pubmed-author:JianYan-linYL,
pubmed-author:QinXuanX,
pubmed-author:UysP BPB,
pubmed-author:WangMin-tingMT,
pubmed-author:WangZhao-danZD,
pubmed-author:XuXue-fanXF,
pubmed-author:YangHong-yunHY,
pubmed-author:YangYun-xiaYX,
pubmed-author:ZhangZhi-rongZR,
pubmed-author:ZhaoChun-yanCY
|
pubmed:issnType |
Electronic
|
pubmed:volume |
5
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
487-97
|
pubmed:meshHeading |
pubmed-meshheading:20957171-Animals,
pubmed-meshheading:20957171-Anti-Inflammatory Agents,
pubmed-meshheading:20957171-Carbon Tetrachloride,
pubmed-meshheading:20957171-Carrageenan,
pubmed-meshheading:20957171-Dexamethasone,
pubmed-meshheading:20957171-Drug Carriers,
pubmed-meshheading:20957171-Liposomes,
pubmed-meshheading:20957171-Liver,
pubmed-meshheading:20957171-Liver Diseases,
pubmed-meshheading:20957171-Mice,
pubmed-meshheading:20957171-Nanomedicine,
pubmed-meshheading:20957171-Nanoparticles,
pubmed-meshheading:20957171-Rats,
pubmed-meshheading:20957171-Rats, Wistar,
pubmed-meshheading:20957171-Tissue Distribution
|
pubmed:year |
2010
|
pubmed:articleTitle |
In vivo biodistribution, anti-inflammatory, and hepatoprotective effects of liver targeting dexamethasone acetate loaded nanostructured lipid carrier system.
|
pubmed:affiliation |
Key Laboratory of Drug Targeting and Drug Delivery System, Ministry of Education, West China School of Pharmacy, Sichuan University, Chengdu, People’s Republic of China.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
In Vitro,
Research Support, Non-U.S. Gov't
|